ID1 and pancreatic adenocarcinoma: In pancreatic adenocarcinoma, emerging evidence suggests that ID1 contributes to tumor aggressiveness by promoting epithelial-mesenchymal transition (EMT) and conferring resistance to chemotherapy (26–29).